Skip to content

Electroacupuncture at Body acupoints and Fenglong (ST 40) for regulating serum lipids in dyslipidemic patients

A randomized controlled trial of electroacupuncture at Body acupoints and Fenglong (ST 40) for regulating serum lipids in dyslipidemic patients in Thailand

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20131003001
Enrollment
60
Registered
2013-10-03
Start date
2013-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemia acupuncture therapy dyslipidemia

Interventions

Participants in group 1 (body acupuncture group) were needled by using disposable silver needles (0.25 x 25 mm) at 20 acupuncture points at the body region including Guanyuan (RN4)&#44
and bilateral Huaroumen (ST24)&#44
Tianshu (ST25)&#44
Shuidao (ST28)&#44
Liangmen (ST21)&#44
Daheng (SP15)&#44
Fujie (SP14)&#44
Zusanli (ST36) and Sanyinjiao (SP6). An electric stimulation (SDZ&#45
II model&#44
Hwato&#44
China) was connected to the needles which delivered a constant current&#44
a 40 Hz and 3 mA&#44
for 30 minutes per session. After each session&#44
the needles were removed. Participants were treated for 2 sessions per week for 8 consecutive weeks.,Participants who were assigned to group 2 (Fenglong Group) were needled at bilateral Fenglong (ST 4
Active Comparator Procedure/Surgery,Active Comparator Procedure/Surgery,No Intervention No treatment
Body acupuncture,Fenglong,Control

Sponsors

Faculty of Medicine, SWU
Lead Sponsor
Srinakharinwirot University
Collaborator

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients who were diagnosed with dyslipidemia (defined as triglycerides ≥ 150 mg/dL, or total cholesterol (TC) ≥ 200 mg/dL or HDL-cholesterol (HDL-C) 130 mg/dL) and were not taking any lipid-lowering drugs were invited to participate in the study.

Exclusion criteria

Exclusion criteria: Patients who had a history of bleeding disorders or were receiving anticoagulant or anti-platelet aggregation medications, had epilepsy, uncontrolled hypertension, and active dermatological lesions at the area of acupuncture, as well as pregnant women or those patients whose mental disabilities made their participation in the study difficult were excluded from the study.

Design outcomes

Primary

MeasureTime frame
an improvement in serum lipid levels at the end of treatment percentage of improvement

Secondary

MeasureTime frame
sustained improvement during the follow-up period 4 weeks at the end of treatment serum lipids

Countries

Thailand

Contacts

Public ContactLakkana Rerksuppaphol

Srinakharinwirot University

lakkana_r@hotmail.com0818483183

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026